search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


TIP-glucocorticoids research UMCU rheumatology; Cardiovascular risk factors and insulin resistency in reumatoid arthritis patients with and without glucocorticoids.


- candidate number2674
- NTR NumberNTR1028
- ISRCTNISRCTN53261020
- Date ISRCTN created23-aug-2007
- date ISRCTN requested13-aug-2007
- Date Registered NTR25-jul-2007
- Secondary IDs 
- Public TitleTIP-glucocorticoids research UMCU rheumatology; Cardiovascular risk factors and insulin resistency in reumatoid arthritis patients with and without glucocorticoids.
- Scientific TitleTIP-glucocorticoids research UMCU rheumatology; Cardiovascular risk factors and insulin resistency in reumatoid arthritis patients with and without glucocorticoids.
- ACRONYMTIP-glucocorticoids research UMCU
- hypothesisWhat is the relation between disease activity, treatment, and metabolic syndrome / insulin resistance.
- Healt Condition(s) or Problem(s) studiedRheumatoid arthritis, Insulin resistance, Cardiovascular risk factors
- Inclusion criteriaDiagnosis reumatoÔd arthritis with disease duration > 2 years.
- Exclusion criterianone
- mec approval receivedno
- multicenter trialno
- randomisedno
- group[default]
- Type[default]
- Studytypeintervention
- planned startdate 1-okt-2007
- planned closingdate1-okt-2010
- Target number of participants300
- Interventions1. Oral Glucose Tolerance Test (OGTT). 2. X-rays of hand, feet, lungs and spinal cord. 3. Electrocardiogram (ECG).
- Primary outcomeMetabolic syndrome / insulin resistence Disease (RA) activity
- Secondary outcome
- Timepoints
- Trial web site
- statusstopped: trial finished
- CONTACT FOR PUBLIC QUERIESBSc, MD, Phd student Jos N. Hoes
- CONTACT for SCIENTIFIC QUERIESBSc, MD, Phd student Jos N. Hoes
- Sponsor/Initiator University Medical Center Utrecht (UMCU), Department of Rheumatology and Clinical Immunology
- Funding
(Source(s) of Monetary or Material Support)
Top Institute Pharma (TI Pharma)
- Publications
- Brief summary- To systematically determine metabolic adverse affects of RA patients, who (chronically) use GCs in order to reduce disease activity, compared to RA patients who donít use GCs. - To study the relation between disease activity, treatment, and metabolic syndrome / insulin resistance.
- Main changes (audit trail)
- RECORD25-jul-2007 - 29-jun-2011


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl